- AI-based Pathology Market Outlook 2035: Artificial Intelligence Transforms Cancer Diagnosis
Market Overview
According to
MarketGenics, the global AI-based
Pathology Market was valued at USD 0.1 billion in 2025 and is projected to
reach USD 0.8 billion by 2035, registering a CAGR of 21.6% during the forecast
period of 2026–2035. The market is expanding as healthcare providers
increasingly adopt artificial intelligence and digital pathology solutions to
improve diagnostic accuracy, accelerate disease detection, and optimize
laboratory workflows. AI-based pathology technologies analyze digitized tissue
samples and whole-slide images to identify abnormalities, classify diseases,
assess biomarkers, and support clinical decision-making. The cancer diagnosis
segment accounts for approximately 39% of the market, driven by the growing
global cancer burden and rising demand for precision oncology. Increasing
adoption of cloud-based pathology platforms, automated image analysis, and
AI-assisted diagnostics is creating significant growth opportunities.
To obtain a free
sample research report - https://marketgenics.co/download-report-sample/ai-based-pathology-market-12418
Market Growth Drivers
The market is driven
by the rising prevalence of cancer and other complex diseases, increasing
demand for faster diagnostic results, and the growing adoption of digital
pathology infrastructure. Healthcare organizations are implementing AI-powered
image analysis, automated tissue classification, biomarker detection, and
predictive diagnostic tools to improve efficiency and reduce variability in
pathology interpretation. The shortage of qualified pathologists and increasing
diagnostic workloads are further encouraging laboratories to adopt AI-enabled
solutions. In addition, integration of pathology images with genomic,
radiology, and clinical data is supporting precision medicine and personalized
treatment planning. Growing investments in cloud-based laboratory platforms,
computational pathology, and AI-powered clinical decision-support systems are
expected to create further market opportunities.
Key Players
Major companies
operating in the global AI-based Pathology Market include F. Hoffmann-La Roche
Ltd., Leica Biosystems Nussloch GmbH, Koninklijke Philips N.V., Siemens
Healthineers AG, Hamamatsu Photonics K.K., Aiforia Technologies Plc, Hologic,
Inc., Indica Labs, Inc., Nucleai Ltd., PathAI, Inc., Proscia Inc., Tempus AI,
Inc., and Visiopharm A/S. These companies are focusing on AI-powered image
analysis, whole-slide imaging, digital pathology software, workflow automation,
and precision oncology solutions. Strategic collaborations, research
investments, and the development of integrated diagnostic platforms are
strengthening competition in the market.
Regional Insights
North America leads
the global AI-based Pathology Market, supported by advanced healthcare
infrastructure, widespread adoption of digital pathology, strong investment in
AI-driven diagnostics, and growing demand for precision cancer diagnosis. The
presence of leading technology developers, diagnostic companies, and research
institutions further supports market expansion. Asia Pacific is experiencing
rapid growth due to increasing investments in digital healthcare, expanding
cancer screening programs, modernization of pathology laboratories, and rising
demand for diagnostic services. Countries such as China, India, Japan, and
South Korea are creating opportunities through AI adoption, digital laboratory
infrastructure, and efforts to address pathologist shortages. Europe also
presents opportunities through digital pathology adoption, precision oncology
programs, and collaboration between healthcare institutions and technology
companies.
Related Reports
Digital
Product Passport Solutions Market
Deepfake
Detection Technology Market
Decentralized
Identity Solutions Market
Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email:
sales@marketgenics.co

Comments
Post a Comment